Browsing All posts tagged under »Excess in the pharmaceutical industry«

Whether created artificially or reflective of a very real and serious issue, pharmaceutical supply chain problems can have deadly consequences for patients

October 7, 2011


“[Patients] don’t know if they will be able to receive their treatment on time. If they are switched to another regimen, they will always wonder if they got the best treatment and therefore the best chances at survival,” she wrote in an e-mail. from the August 18th, 2011 Globe & Mail article “Health Canada warns […]